Skip to content

Using photo-documentation to improve detection of stomach and oesophagus problems during endoscopy

Gastroscopy Improvement (GastroProve) Study: A randomised controlled trial evaluating the effect of structured photo-documentation on lesion detection rates during oesophagogastroduodenoscopy in surgical trainees using high-fidelity simulatio

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10549726
Enrollment
16
Registered
2025-10-27
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper gastrointestinal disease, including gastric and oesophageal lesions (e.g., ulcers, polyps, early gastric cancer)

Interventions

Intervention: Participants in the intervention group will receive structured instruction on the British Society of Gastroenterology (BSG) eight-landmark photo-documentation protocol for oesophagogastr

Sponsors

Royal College of Surgeons in Ireland
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Surgical trainee at Senior House Officer (SHO) level or equivalent. 2. Enrolled in a postgraduate surgical training programme with exposure to upper GI endoscopy. 3. Some prior exposure to oesophagogastroduodenoscopy (observation or supervised performance). 4. Able and willing to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Extensive prior independent endoscopy experience (e.g., JAG-certified). 2. Previous participation in similar OGD simulation studies. 3. Inability or unwillingness to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Lesion detection rate during OGD — proportion of pathology-positive simulated cases in which the trainee correctly identifies a lesion and assigns the correct anatomical localisation, assessed via the simulator’s image-based reporting workflow at the end of each case (images must be labelled to site and pathology declared). Measured per participant across their five pathology-positive cases and compared between groups.

Secondary

MeasureTime frame
1. Procedure completion time: Time (minutes/seconds) to complete each simulated OGD, captured automatically by the simulator; summarised per participant across 10 cases and compared between groups. 2. Adherence to photo-documentation guidance: Number and distribution of anatomical sites imaged per case (e.g., proportion of required landmarks captured); summarised per participant and compared between groups. 3. Additional descriptive measure: Baseline trainee experience and knowledge relevant to OGD quality and photo-documentation from the pre-study questionnaire, used to characterise the cohort and as covariates in sensitivity analyses.

Countries

Ireland

Contacts

Public ContactEoghan Burke
eoghanburke@rcsi.ie+353 1 402 2100

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026